DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activityAlexander Muik(BioNTech (Germany)), Maria Jure‐Kunkel(Genmab (United States))Journal for ImmunoTherapy of CancerJune 1, 202210.1136/jitc-2021-004322Cited by 36SaveCiteExport RISWatch citationsRelated PapersSupplementary Figure from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors|Unknown|2023|0